Say No To Trading
Public Markets Investor, Opportunistic Buying & Cost-Basis Management
IonQ's growing backlog and faster chip production strengthen its bullish case by securing future revenue and shortening production time. Q2 revenue jumped 287% YoY to $80M, beating expectations for a fifth straight quarter; backlog quadrupled to $485M and 2026 revenue guidance rose to $450M-$460M. SkyWater cuts chip production from nine to two months; 256-qubit bookings opened for early 2027 delivery, and the $1.3B Elisity acquisition targets quantum cybersecurity. x.comÂ
IonQ's capital infusion strengthens its fundamentals despite the dilution cost to shareholders. Elisity cost the company no additional capital because the acquisition was paid entirely in stock. x.com x.comÂ
IonQ's management has shifted from talking about technology to acquisitions, a warning sign. It bought a low-quality SkyWater fab and Oxford Ionics, a 40-person team hitting 99.99% two-qubit fidelity but at about 10,000 nanoseconds, while Google, IBM and Rigetti teams are at 25-30 ns. IonQ's earlier technology may be phased out, forcing a pivot, and customer announcements look aimed at steering attention from tech comparisons. Without far higher fidelity at speed, it is garbage in, garbage out. … Show more
IonQ's acquisitions could compound by easing quantum scaling bottlenecks. IonQ says its chip cycle fell from nine to two months with SkyWater; Oxford Ionics, Nexus Photonics and Lightsynq add control, optics and interconnects. Networking, sensing and space may gain value before fault-tolerant computing. Its ecosystem may already be the world's most complex: ten investors might form ten theses with at most 75% overlap, perhaps overstated. Integration is hard; not every deal may deliver. x.com … Show more
Elisity could let IonQ earn security revenue before quantum computing reaches mass adoption. Its network controls complement quantum-safe encryption as customers prepare for harvest-now-decrypt-later attacks; AI agents could add demand. IonQ is now one of the most strategically important quantum security plays, but the roughly $1.3B deal adds integration risk amid strong competitors. Investors must watch whether security revenue grows organically or through more acquisitions. x.comÂ
IonQ's acquisition of Elisity may make strategic sense but looks like a terrible deal at up to $1.3 billion, paid entirely in IonQ shares. The microsegmentation startup would cost roughly 9% of the company. x.comÂ
IonQ is forming a massive cup pattern on heavy institutional accumulation, with institutions more than doubling their holdings over the past year. The quantum theme is also heating up, as Honeywell's Quantinuum IPO is reportedly 20x oversubscribed and begins trading today. x.comÂ
IonQ is now the only US quantum company with its own American chip factory, opening defense and intelligence customers that must source from US-controlled fabs. The SkyWater facility in Minnesota is a 200mm ITAR-compliant fab with quantum-relevant experience, giving IonQ control of its supply chain, roadmap and production timeline as the CHIPS Act encourages. This adds to a quarter of $65M revenue versus $50M expected, guidance raised to $265M and RPO up 554%. x.comÂ
IonQ is hurting shareholders with a $2B raise to fund an acquisition that makes its business worse. Raising the money was a choice, not a necessity. The offering includes 20.5M common shares at $40 each and pre-funded warrants to purchase 29.5M shares at $40 per warrant, plus seven-year warrants for another 100M shares at $69.46. x.com x.comÂ
IonQ, Rigetti and Infleqtion are the next stocks Trump is effectively calling, now that he says the US aims to have a quantum computer for scientific discovery by 2028. His earlier signals preceded big gains in Intel, Dell and Micron. x.comÂ